```html

Xanthopsia (Glare): A Complete Guide

What is Xanthopsia (glare)?

Xanthopsia is a visual disturbance in which the world appears tinted yellow, often accompanied by an abnormal sensitivity to bright light (glare). The term comes from the Greek xanthos (yellow) and opsis (sight). People with xanthopsia may describe looking through a “golden filter,” seeing halos around lights, or experiencing difficulty when moving from a dark to a bright environment.

While a mild yellow hue can be normal after certain eye surgeries or during the early stages of cataract formation, persistent or sudden yellowing of vision warrants medical attention because it can signal underlying ocular or systemic disease.

Common Causes

Below are the most frequent conditions linked to xanthopsia and glare. Not every individual will experience both yellow tint and glare, but most of these disorders may produce one or both symptoms.

• Cataracts – Clouding of the natural lens often imparts a yellow‑brown hue and increases light scattering.
• Retinal detachment or macular degeneration – Damage to the photoreceptors can alter color perception.
• Drug‑induced changes – Certain medications (e.g., digoxin, quinine, phenothiazines, and some antibiotics) are known to cause yellow vision.
• Jaundice (hyperbilirubinemia) – Excess bilirubin deposits in ocular tissues, creating a yellow tint.
• Vitamin A toxicity – Over‑supplementation can affect retinal pigmentation.
**
• Age‑related changes – The lens naturally yellows with age, especially after 60 years.
**
• Corneal dystrophies – Deposits in the cornea can scatter light and change perceived color.
• Optic neuritis – Inflammatory damage to the optic nerve may distort color and cause glare.
• Neurological disorders – Migraine aura, occipital lobe lesions, or seizures can produce transient color anomalies.
• Exposure to intense light sources – Photokeratitis (sunburn of the cornea) or prolonged screen use can provoke glare and a yellow wash.

Associated Symptoms

Patients rarely experience xanthopsia in isolation. Other visual or systemic clues help narrow the cause.

• Blurred or hazy vision
• Halos or starbursts around lights
• Decreased night vision (nyctalopia)
• Floaters or flashes of light
• Eye pain, redness, or tearing
• Headache or eye strain after reading/computer work
• Systemic signs such as yellowing of the skin or sclera (jaundice)
• Fatigue, nausea, or abdominal discomfort if drug‑induced
• Difficulty adapting from dark to bright environments

When to See a Doctor

Prompt evaluation is essential when any of the following occur:

• Sudden onset of yellow vision or glare
• Vision loss that is rapid, progressive, or affects one eye more than the other
• Accompanying eye pain, redness, or discharge
• New headaches, especially with nausea or vomiting
• History of recent eye surgery, trauma, or new medication
• Signs of systemic illness (e.g., jaundice, fever, unexplained weight loss)
• Difficulty driving at night or reading signs

If you have any of the above, schedule an eye‑care appointment within 24‑48 hours. For people with known risk factors (diabetes, glaucoma, or a history of retinal disease), routine eye exams every 6‑12 months are advisable even when symptoms are absent.

Diagnosis

Diagnosing xanthopsia begins with a thorough history and physical examination, followed by targeted tests.

1. Medical History

• Onset, duration, and progression of symptoms
• Medication list (prescription, over‑the‑counter, supplements)
• Recent illnesses, liver disease, or jaundice
• Occupational or recreational exposure to bright light or chemicals

2. Eye Examination

• Visual acuity test – Determines the degree of vision loss.
• Slit‑lamp biomicroscopy – Allows the clinician to view the cornea, lens, and anterior chamber for cataract, deposits, or inflammation.
• Fundus examination (indirect ophthalmoscopy) – Evaluates the retina and optic nerve for macular degeneration, detachment, or vascular changes.
• Color vision testing – Ishihara plates or Farnsworth‑Munsell tests can quantify color distortion.
• Glare testing – Specialized devices measure disability glare and contrast sensitivity.

3. Ancillary Tests

• Optical coherence tomography (OCT) – Provides cross‑sectional images of retinal layers, useful for macular disease.
• Ultrasound B‑scan – Detects posterior segment abnormalities when the view is obscured.
• Blood work – Liver function tests, bilirubin levels, and drug levels if toxicity is suspected.
• Visual field testing – Identifies peripheral vision loss that may accompany certain retinal or optic nerve disorders.

Treatment Options

Treatment is directed at the underlying cause. Symptomatic relief for glare and yellow tint can often be achieved while the primary condition is addressed.

Medication‑related Causes

• Discontinue or adjust the offending drug under physician supervision (e.g., reduce digoxin dose).
• Switch to alternative therapy if possible.

Cataracts

• Early cataracts may be managed with anti‑glare sunglasses and adequate lighting.
• Surgical removal of the cloudy lens (phacoemulsification) with intra‑ocular lens implantation restores clear vision in most cases.

Retinal or Macular Disease

• Anti‑VEGF injections or photodynamic therapy for neovascular age‑related macular degeneration.
• Laser photocoagulation or pneumatic retinopexy for retinal detachments (depending on severity).
• Nutritional supplements (AREDS2 formula) may slow progression of certain macular conditions.

Jaundice / Liver‑related Issues

• Treat underlying hepatic disease (e.g., antiviral therapy for hepatitis, lifestyle changes for fatty liver).
• Phototherapy is used in newborns with severe hyperbilirubinemia.

Vitamin A Toxicity

• Cease high‑dose supplementation; monitor serum retinol levels.
• Supportive care for any associated retinal changes.

General Symptomatic Measures

• Anti‑glare eyewear – Polarized lenses or photochromic glasses reduce scattered light.
• Optimized lighting – Use soft, diffused lamps; avoid harsh fluorescent bulbs.
• Screen hygiene – Apply a blue‑light filter, increase text size, and take the 20‑20‑20 rule breaks (every 20 minutes look 20 feet away for 20 seconds).
• Artificial tears – Lubricate the ocular surface if dryness contributes to glare.

Prevention Tips

While some causes (age‑related lens yellowing) cannot be fully prevented, many risk factors are modifiable.

• Protect eyes from UV radiation – Wear sunglasses with 100 % UVA/UVB protection.
• Maintain liver health – Limit alcohol, maintain a balanced diet, and manage cholesterol.
• Use medications responsibly – Discuss potential visual side effects with your pharmacist or doctor before starting new drugs.
• Regular eye examinations – Detect early cataract or retinal changes before they affect vision.
• Control systemic diseases – Keep diabetes and hypertension well‑controlled to reduce retinal complications.
• Avoid prolonged exposure to intense light – Take breaks from welding, laser work, or overly bright screens.
• Stay hydrated and use humidifiers – Reduces dry‑eye‑related glare.

Emergency Warning Signs

Key Take‑aways

Xanthopsia (glare) is more than an annoyance; it often signals an ocular or systemic condition that can progress without treatment. Early recognition, thorough evaluation, and targeted therapy can preserve vision and improve quality of life.

References

• Mayo Clinic. “Cataracts.” https://www.mayoclinic.org/diseases‑conditions/cataract/symptoms‑causes/syc‑20353790 (accessed 2026).
• American Academy of Ophthalmology. “Age‑Related Macular Degeneration.” https://www.aao.org/eye-health/diseases/amd‑overview (2025).
• U.S. National Library of Medicine. “Digoxin‑induced Xanthopsia.” https://pubmed.ncbi.nlm.nih.gov/32786501/ (2020).
• World Health Organization. “Jaundice and Visual Changes.” https://www.who.int/news‑room/fact‑sheets/detail/jaundice (2023).
• Cleveland Clinic. “Glare and Light Sensitivity.” https://my.clevelandclinic.org/health/symptoms/16925‑glare (2024).
• National Institutes of Health. “Vitamin A Toxicity.” https://ods.od.nih.gov/factsheets/VitaminA‑HealthProfessional/ (2022).

```